GAMGERTAMIG
UNII SW2QD6CHA2

Substance Identification & Data

This profile provides standardized clinical and technical data for Gamgertamig, uniquely identified by the FDA Unique Ingredient Identifier (UNII) SW2QD6CHA2.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3038119-48-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
SW2QD6CHA2
CAS Registry Number
3038119-48-8
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
GAMGERTAMIG
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C224743
National Cancer Institute reference terminology for clinical and research data.
INN ID
13797
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Gamgertamig. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

GAMGERTAMIG

Common Names & Synonyms

GAMGERTAMIG [INN]
IMMUNOGLOBULIN (H-GAMMA4_L-KAPPA)_(H-GAMMA4_L-LAMBDA2), ANTI-(HOMO SAPIENS TNFRSF17 (TUMOR NECROSIS FACTOR (TNF) RECEPTOR SUPERFAMILY MEMBER 17, B CELL MATURATION ANTIGEN, BCMA, TNFRSF13A, CD269)) AND ANTI-(HOMO SAPIENS CD3E (CD3 EPSILON, LEU-4)), MONOCLONAL ANTIBODY, BISPECIFIC, BIVALENT (GAMGERTAMIG)
IMMUNOGLOBULIN G4, BISPECIFIC, (233-PROLINE,240-GLUTAMIC ACID,334-ALANINE,359-CYSTEINE,371-TRYPTOPHAN,414-LYSINE), ANTI-(HUMAN CD ANTIGEN .EPSILON.-CHAIN (4-LEUCINE)) (HUMAN-MUS MUSCULUS MONOCLONAL HSP34 H9K5 .GAMMA.4-CHAIN), (139-214''')-DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL HSP34 H9K5 .LAMBDA.-CHAIN, (231->228'),(234->231'),(359->351')-TRIS(DISULFIDE) WITH IMMUNOGLOBULIN G4 (230-PROLINE,237-GLUTAMIC ACID,331-ALANINE,351-CYSTEINE,368-SERINE,370-ALANINE,409-VALINE,411-LYSINE) ANTI-(HUMAN TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY PROTEIN TNFRSF17) (HUMAN-MUS MUSCULUS MONOCLONAL H29A11 H3K2 .GAMMA.4-CHAIN), (136'->218'')-DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL H29A11 H3K2 .KAPPA.-CHAIN

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus